John Darmawan
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Pharmacology top 2%
- Musculoskeletal pain and rehabilitation
Papers in
- Pharmacology 11
- Musculoskeletal pain and rehabilitation 11
-
- Rheumatoid Arthritis Research and Therapies 7
- Spondyloarthritis Studies and Treatments 2
- Osteoarthritis Treatment and Mechanisms 1
- Co-authors
- Shun Le Chen (4 shared papers)Qing Yu Zeng (3 shared papers)R. D. Wigley (3 shared papers)Ren Chen (3 shared papers)Zheng Yu Xiao (3 shared papers)Jonathan Parker (1 shared paper)Syed Atiqul Haq (5 shared papers)Johannes Jacobus Rasker (7 shared papers)
- Journals
- The Journal of Rheumatology (1 paper)Clinical Rheumatology (1 paper)Arthritis Research & Therapy (1 paper)International Journal of Technology Assessment in Health Care (1 paper)International Journal of Rheumatic Diseases (3 papers)
- Partner nations
- SwitzerlandChinaBangladesh
In The Last Decade
John Darmawan
19 papers receiving 938 citations
Peers
Comparison fields: 5 of 73
- Rheumatology 465
- Pharmacology 369
- Nephrology 116
- Rehabilitation 38
- Psychiatry and Mental health 54
Countries citing papers authored by John Darmawan
This map shows the geographic impact of John Darmawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Darmawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Darmawan more than expected).
Fields of papers citing papers by John Darmawan
This network shows the impact of papers produced by John Darmawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Darmawan. The network helps show where John Darmawan may publish in the future.
Co-authors
The 23 scholars most cited alongside John Darmawan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 309 | |
| 2 | Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. | 2005 | 183 |
| 3 | Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. | 2004 | 115 |
| 4 | Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. | 2003 | 96 |
| 5 | Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. | 2004 | 64 |
| 6 | 2010 | 42 | |
| 7 | 2007 | 36 | |
| 8 | 1995 | 25 | |
| 9 | The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years. | 2003 | 24 |
| 10 | Risk factors associated with rheumatic complaints: a WHO-ILAR COPCORD study in Shantou, Southeast China. | 2005 | 23 |
| 11 | Characteristics of chronic gout in Northern Sulawesi, Indonesia. | 2006 | 20 |
| 12 | 2008 | 15 | |
| 13 | 2008 | 15 | |
| 14 | Reduced burden of disease and improved outcome of patients with rheumatoid factor positive rheumatoid arthritis compared with dropouts. A 10 year observational study. | 2003 | 10 |
| 15 | 1995 | 8 | |
| 16 | Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases. | 2006 | 6 |
| 17 | Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy. | 2004 | 3 |
| 18 | Ten years radiographic outcome of rheumafactor positive rheumatoid arthritis patients treated with aggressive low dose immunosuppressive combination therapy. | 2004 | 3 |
| 19 | The effect of control and self-medication of chronic gout in a developing country. | 2003 | 2 |
About John Darmawan
John Darmawan is a scholar working on Pharmacology, Rheumatology, Nephrology, Rehabilitation and Education, having authored 19 papers that have together received 999 indexed citations. Recurring topics across this work include Musculoskeletal pain and rehabilitation (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Musculoskeletal Disorders and Rehabilitation (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Health Education and Validation (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Rheumatology (465 citations), Pharmacology (369 citations), Nephrology (116 citations), Rehabilitation (38 citations) and Psychiatry and Mental health (54 citations). John Darmawan has collaborated with scholars based in Switzerland, China and Bangladesh. Frequent co-authors include Shun Le Chen, Qing Yu Zeng, R. D. Wigley, Ren Chen, Zheng Yu Xiao, Jonathan Parker, Syed Atiqul Haq, Johannes Jacobus Rasker, Mohammad Aumran Tahir and Fazlur Rahman. Their work appears in journals such as The Journal of Rheumatology, Clinical Rheumatology, Arthritis Research & Therapy, International Journal of Technology Assessment in Health Care and International Journal of Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.